🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/11/2022 | 99,00 | 99,38 | 97,96 | 99,20 | +0,46% | 1,43% | 8.877.600 |
| 03/11/2022 | 99,00 | 99,24 | 98,00 | 98,75 | -0,65% | 1,25% | 9.912.700 |
| 02/11/2022 | 99,65 | 101,03 | 98,98 | 99,40 | -0,36% | 2,06% | 9.503.500 |
| 01/11/2022 | 100,65 | 101,07 | 98,95 | 99,76 | -1,42% | 2,11% | 11.079.300 |
| 31/10/2022 | 99,95 | 101,36 | 99,31 | 101,20 | +0,43% | 2,05% | 11.043.800 |
| 28/10/2022 | 100,24 | 101,14 | 98,55 | 100,77 | +1,03% | 2,58% | 11.228.000 |
| 27/10/2022 | 99,84 | 101,50 | 99,50 | 99,74 | +1,35% | 2,00% | 12.218.400 |
| 26/10/2022 | 98,29 | 99,28 | 98,00 | 98,41 | +0,72% | 1,30% | 10.374.700 |
| 25/10/2022 | 96,86 | 98,29 | 96,35 | 97,71 | +0,35% | 2,00% | 8.747.900 |
| 24/10/2022 | 96,45 | 98,42 | 96,27 | 97,37 | +1,78% | 2,23% | 11.414.900 |
| 21/10/2022 | 92,84 | 95,96 | 92,64 | 95,67 | +2,94% | 3,58% | 10.297.200 |
| 20/10/2022 | 93,20 | 93,40 | 92,36 | 92,94 | -0,34% | 1,12% | 7.626.000 |
| 19/10/2022 | 94,91 | 94,91 | 93,10 | 93,26 | -1,43% | 1,91% | 8.546.100 |
| 18/10/2022 | 94,42 | 95,32 | 94,02 | 94,61 | +0,52% | 1,38% | 9.530.400 |
| 17/10/2022 | 92,84 | 94,37 | 92,45 | 94,12 | +2,10% | 2,07% | 12.139.700 |
| 14/10/2022 | 92,27 | 93,36 | 91,74 | 92,18 | -0,34% | 1,76% | 9.847.600 |
| 13/10/2022 | 89,50 | 92,72 | 89,27 | 92,49 | +2,29% | 3,85% | 9.382.800 |
| 12/10/2022 | 91,25 | 91,72 | 90,37 | 90,42 | -0,69% | 1,48% | 8.522.200 |
| 11/10/2022 | 90,43 | 91,98 | 90,20 | 91,05 | +0,63% | 1,97% | 9.743.500 |
| 10/10/2022 | 89,93 | 91,59 | 89,71 | 90,48 | +3,29% | 2,09% | 14.485.000 |
| 07/10/2022 | 87,88 | 88,30 | 87,12 | 87,60 | +0,18% | 1,34% | 8.837.400 |
| 06/10/2022 | 87,76 | 88,01 | 87,23 | 87,44 | -1,07% | 0,89% | 8.055.500 |
| 05/10/2022 | 88,58 | 88,78 | 88,02 | 88,39 | +0,00% | 0,86% | 6.065.700 |
| 04/10/2022 | 87,54 | 88,65 | 87,00 | 88,39 | +0,96% | 1,88% | 7.373.000 |
| 03/10/2022 | 86,72 | 87,90 | 86,02 | 87,55 | +1,66% | 2,17% | 9.186.900 |
| 30/09/2022 | 87,25 | 87,62 | 86,10 | 86,12 | -0,60% | 1,74% | 9.035.600 |
| 29/09/2022 | 87,00 | 87,42 | 86,23 | 86,64 | -0,16% | 1,37% | 6.601.300 |
| 28/09/2022 | 86,99 | 87,25 | 86,20 | 86,78 | +1,10% | 1,21% | 6.840.000 |
| 27/09/2022 | 86,82 | 87,63 | 85,67 | 85,84 | -0,39% | 2,26% | 6.532.100 |
| 26/09/2022 | 86,12 | 86,71 | 85,29 | 86,18 | -0,69% | 1,65% | 8.841.000 |